· 3 issues
The April 1973 issue of HealthPAC Bulletin focuses on the critical state of public hospitals in the U.S., particularly in California, where many county hospitals are facing closure due to financial strains exacerbated by Medicaid cutbacks. The article highlights the shifting burden of healthcare costs back to local governments as federal support wanes, with private hospitals increasingly refusing to accept low-income patients. Notable discussions include the implications of the 1972 Airlie House Conference on Public Hospitals and the ongoing struggles in cities like Chicago and San Francisco to maintain public healthcare access amidst privatization pressures. The issue emphasizes the need for grassroots organizing to preserve public hospitals as essential healthcare providers for low-income communities.
The January-February 1983 issue of HealthPAC Bulletin highlights the ongoing challenges in healthcare policy, particularly focusing on the implications of the new Medicare reimbursement system based on Diagnostic Related Groups (DRGs). The issue features a critical examination of the drug policies in Bangladesh, emphasizing the influence of multinational pharmaceutical companies like Pfizer on local healthcare decisions. Notable articles discuss the financial misconduct of healthcare institutions, as reported by the General Accounting Office, revealing systemic fraud in Medicare and Medicaid reimbursements. The issue also includes a letter from Erica Gollub addressing the complexities of drug pricing and availability in Bangladesh, underscoring the tension between corporate interests and public health needs.
The July-August 1985 issue of HealthPAC Bulletin focuses on critical health issues affecting marginalized populations, particularly the homeless and those impacted by environmental pollution. Notable articles include 'The Sickness That Won't Heal,' which discusses the healthcare challenges faced by the nation's homeless, and 'AIDS: The Impending Quarantine,' which addresses the growing crisis of AIDS and its societal implications. The issue also highlights the Hanrahan family's legal battle against Merck in Ireland, raising questions about corporate accountability and environmental health. Overall, the Bulletin emphasizes the need for systemic change in health policy to address these pressing issues.